RMD ResMed Inc.
ResMed, Inc. engages in the development, manufacturing, distribution, and marketing of medical equipment and software solutions. The company operates through the following segments: Sleep and Respiratory Care, and SaaS. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The SaaS segment engages in the supply of business management software as a service to out-of-hospital health providers. Its product portfolio includes devices, diagnostic products, mask systems, headgear and other accessories, and dental devices. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.
Company profile
Ticker
RMD
Exchange
Website
CEO
Michael J. Farrell
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
3M • Boston Scientific • Baxter International • Stryker • Becton Dickinson and • Teleflex • Hill-Rom • Integra LifeSciences • Haemonetics • NuVasive ...
SEC CIK
Corporate docs
IRS number
980152841
RMD stock data
()
Calendar
13 Aug 20
24 Sep 20
30 Jun 21
News
Financial summary
| Quarter (USD) | Mar 20 | Dec 19 | Sep 19 | Mar 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Jun 20 | Jun 19 | Jun 18 | Jun 17 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
Financial data from ResMed earnings reports.
Recent insider trades
| Date | Owner | Security | Transaction | Code | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|
| 15 Sep 20 | Douglas Robert Andrew | ResMed Common Stock | Sell | Dispose S | Yes | 175.49 | 1,147 | 201.29K | 183,438 |
| 15 Sep 20 | Sandercock Brett | ResMed Common Stock | Sell | Dispose S | Yes | 175.49 | 2,500 | 438.73K | 86,775 |
| 3 Sep 20 | David Pendarvis | ResMed Common Stock | Sell | Dispose S | Yes | 177.5155 | 5,919 | 1.05M | 136,128 |
| 3 Sep 20 | David Pendarvis | ResMed Common Stock | Option exercise | Aquire M | Yes | 57.76 | 5,919 | 341.88K | 142,047 |
| 3 Sep 20 | David Pendarvis | ResMed Common Stock Options ResMed Common Stock | Option exercise | Dispose M | No | 57.76 | 5,919 | 341.88K | 11,837 |
| 1 Sep 20 | Rajwant Sodhi | ResMed Common Stock | Sell | Dispose S | Yes | 181 | 1,500 | 271.5K | 34,089 |
| 1 Sep 20 | James Hollingshead | ResMed Common Stock | Sell | Dispose S | Yes | 202.0223 | 2,400 | 484.85K | 92,402 |
Institutional ownership Q2 2020
69.4% owned by funds/institutions
13F holders |
Current |
|---|---|
| Total holders | 569 |
| Opened positions | 68 |
| Closed positions | 71 |
| Increased positions | 223 |
| Reduced positions | 201 |
13F shares |
Current |
|---|---|
| Total value | 243.55B |
| Total shares | 100.6M |
| Total puts | 459.8K |
| Total calls | 343.7K |
| Total put/call ratio | 1.3 |
Largest owners |
Shares | Value |
|---|---|---|
| Vanguard | 15.99M | $3.07B |
| BLK BlackRock | 13.2M | $2.54B |
| WCM Investment Management | 8.47M | $1.63B |
| STT State Street | 6.71M | $1.29B |
| FMR | 5.41M | $1.04B |
| Capital World Investors | 5.34M | $1.02B |
| Baillie Gifford & Co | 4.55M | $873.44M |
| Geode Capital Management | 2.45M | $470.13M |
| IVZ Invesco | 2.27M | $435.48M |
| NTRS Northern Trust | 2.12M | $406.88M |
Financial report summary
?
Content analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
abruptly, accommodate, addressing, Aid, APAP, architecture, ARRC, bug, caption, Carolina, category, CCPA, certiorari, CIA, Circuit, CJEU, cloud, collateralization, comorbid, comorbidity, constrained, context, corruption, cybersecurity, debarment, delete, departure, deploy, deployed, destination, deterred, dissatisfaction, dissatisfied, diversification, duration, endeavored, entry, exploit, extreme, feasible, fine, frequency, GI, greatest, guarantor, hamper, healthier, hosting, inception, infected, infection, instrument, Iowa, joined, journey, lowest, MaskSelector, meant, mechanical, mechanism, membership, minimalist, mission, mitigated, mobility, NaN, OOH, OPEL, opt, outbreak, outreach, overcome, oversupply, overview, pandemic, postpone, postponed, postponing, prioritization, prioritized, profile, recipient, reclassification, reluctant, remanded, remitted, resumption, resurgence, ROU, satisfaction, sea, sequester, short, signature, SnapWorx, society, SOFR, space, spread, standalone, Stellar, strain, Subtopic, Supreme, switch, Thailand, thousand, travel, Ultra, unadjusted, unavailability, uncollectible, unconsolidated, unconstitutional, undrawn, unwilling, urgent, windfall, withheld, worsen
Removed:
absent, absolute, AcuCare, adhering, AllCall, automate, cancellation, Chinese, clarification, clarity, compact, compromising, Conduit, Connect, constantly, constituting, convenient, cooperating, counter, derive, discomfort, disordered, distributor, divided, drying, EasyCare, encompassing, escape, foam, formally, format, frame, GmbH, heat, HFNC, historically, implied, interchangeability, KG, managing, Mehmet, Modular, obligated, OIG, online, Oz, permeable, powered, procurement, project, promised, PRSU, RCM, rehabilitation, reinstated, representing, requesting, ResControl, ResLink, ResScan, ResTraxx, seal, seamlessly, settle, simplicity, SleepScore, smallest, staggered, subpoena, sweat, TxControl, Ultrasoft
Financial reports
10-K
2020 FY
Annual report
13 Aug 20
10-Q
2020 Q3
Quarterly report
1 May 20
10-Q
2020 Q2
Quarterly report
31 Jan 20
10-Q
2020 Q1
Quarterly report
25 Oct 19
10-K
2019 FY
Annual report
8 Aug 19
10-Q
2019 Q3
Quarterly report
3 May 19
10-Q
2019 Q2
Quarterly report
1 Feb 19
10-Q
2019 Q1
Quarterly report
26 Oct 18
10-K
2018 FY
Annual report
17 Aug 18
10-Q
2018 Q3
Quarterly report
27 Apr 18
Current reports
8-K
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2020
5 Aug 20
8-K
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2020
30 Apr 20
8-K
Amendments to Articles of Incorporation or Bylaws
26 Feb 20
8-K
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2020
30 Jan 20
8-K
Submission of Matters to a Vote of Security Holders
22 Nov 19
8-K
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2020
24 Oct 19
8-K
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2019
25 Jul 19
8-K
Entry into a Material Definitive Agreement
15 Jul 19
8-K
Departure of Directors or Certain Officers
16 May 19
8-K
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2019
2 May 19
Registration and prospectus
S-8
Registration of securities for employees
13 Aug 20
S-8
Registration of securities for employees
30 Apr 18
S-8
Registration of securities for employees
28 Feb 14
S-8
Registration of securities for employees
1 Feb 13
S-8
Registration of securities for employees
10 May 12
S-8
Registration of securities for employees
28 May 10
S-8
Registration of securities for employees
26 Jan 10
S-8
Registration of securities for employees
11 Dec 08
S-8
Registration of securities for employees
31 Jan 07
S-8
Registration of securities for employees
31 Jan 07
Proxies
DEFA14A
Additional proxy soliciting materials
8 Oct 19
DEF 14A
Definitive proxy
8 Oct 19
DEFR14A
Revised proxy
31 Oct 18
DEFA14A
Additional proxy soliciting materials
3 Oct 18
DEF 14A
Definitive proxy
3 Oct 18
DEFA14A
Additional proxy soliciting materials
26 Sep 17
DEF 14A
Definitive proxy
25 Sep 17
DEF 14A
Definitive proxy
26 Sep 16
DEF 14A
Definitive proxy
1 Oct 15
DEFA14A
Additional proxy soliciting materials
1 Oct 15
Other
SD
Conflict minerals disclosure
22 May 20
SD
Conflict minerals disclosure
22 May 19
SD
Conflict minerals disclosure
29 May 18
SD
Conflict minerals disclosure
24 May 17
UPLOAD
Letter from SEC
17 Jan 17
UPLOAD
Letter from SEC
5 Jan 17
CORRESP
Correspondence with SEC
20 Dec 16
UPLOAD
Letter from SEC
29 Nov 16
SD
Conflict minerals disclosure
31 May 16
UPLOAD
Letter from SEC
15 Dec 15
Ownership
4
RESMED / Brett Sandercock ownership change
16 Sep 20
4
RESMED / Robert Andrew Douglas ownership change
16 Sep 20
4
RESMED / DAVID PENDARVIS ownership change
4 Sep 20
4
RESMED / James Hollingshead ownership change
2 Sep 20
4
RESMED / Rajwant Sodhi ownership change
2 Sep 20
4
RESMED / Brett Sandercock ownership change
19 Aug 20
4
RESMED / Robert Andrew Douglas ownership change
18 Aug 20
4
RESMED / Richard McHale ownership change
17 Aug 20
4
RESMED / Brett Sandercock ownership change
17 Aug 20
4
RESMED / DAVID PENDARVIS ownership change
17 Aug 20
Patents
APP
Utility
Remote Diagnostics of Respiratory Therapy Devices
27 Aug 20
A system and method is disclosed for performing diagnostics on patient devices.
APP
Utility
Secure Networked Respiratory Therapy Systems
20 Aug 20
Methods and apparatus provide communications among respiratory therapy device (“TD”), server and intermediary (e.g., a control device (“CTLD”) for the therapy device) to improve security.
APP
Utility
Compression Apparatus and Systems for Circulatory-related Disorders
30 Jul 20
A compression garment for providing circulatory-related disorder therapy includes a skin contacting layer, a second layer, and one or more connectors.
APP
Utility
System and Method for Medical Device Identifier
7 May 20
A method and system assists in management of data associated with a home medical equipment (HME) device provided to a patient.
APP
Utility
System and Method for Tracking Medical Device Usage
7 May 20
A system provides medical device data to a system user.